Porcine neural cell product - Diacrin
Latest Information Update: 23 Jan 2017
At a glance
- Originator Diacrin
- Class Cell therapies
- Mechanism of Action Nerve growth factor stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Discontinued Stroke
Most Recent Events
- 23 Jan 2017 Discontinued - Phase-I for Stroke in USA (Intracerebral)
- 27 Jun 2000 Suspended-I for Stroke in USA (Intracerebal)